相关实验视频

Updated: Jul 9, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

前列腺导管内癌的分子变化前列腺导管内癌

Marit Bernhardt¹, Glen Kristiansen¹

¹Institute of Pathology, University Hospital Bonn, 53127 Bonn, Germany.

|December 9, 2023

概括

前列腺导管内癌 (IDC-P) 与高级前列腺癌具有共同的遗传变化,如PTEN损失. 孤立的IDC-P,虽然较罕见,但显示出明显的分子特征和不同的遗传改变频率.

科学领域:

泌尿器科泌尿器科泌尿器科泌尿器科
在瘤学瘤学.
分子生物学分子生物学

背景情况:

前列腺导管内癌 (IDC-P) 经常与高度侵入性前列腺癌一起发现.
孤立的IDC-P,没有相邻的入侵性癌症,是一个公认的但不太常见的实体.

研究的目的:

研究IDC-P的分子特性,将与高度癌症相关的病例与孤立的IDC-P进行比较.
在不同的IDC-P环境中识别共同和独特的遗传变异.

主要方法:

对遗传变化的分析,包括PTEN损失,TP53和RB1的LOH,SPOP突变和ERG融合.
对IDC-P与相邻的高度癌症和孤立的IDC-P之间的分子配置进行比较.
利用像TCGA这样的分子子集的数据.

主要成果:

与高级癌症相关的IDC-P经常表现出PTEN损失 (69-84%) 和TP53和RB1LOH的更高率.
在IDC-P中,SPOP突变更为普遍,特别是在TCGA分子子集中.
孤立的IDC-P较少见,PTEN损失率 (47%) 和ERG融合率 (7%) 较低.

结论:

在IDC-P的遗传变化往往反映在相邻的高度前列腺癌.
在IDC-P与没有相邻的高度癌症之间存在不同的分子概况.
虽然BRCA2损失,PTEN损失和SPOP突变与IDC-P的发展有关,但它们的致病作用需要进一步验证.

关键词:

形前列腺癌 (cribriform) 是一种前列腺癌.前列腺内导管癌的前列腺癌.导管内传播的扩散.

更多相关视频

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...